Prescription Drug Supply Chain Pricing Transparency Act

Key Points

• Senators Bennet and Lankford introduced a bill to investigate how "middleman" companies in the drug industry make their money and how that affects what you pay at the pharmacy.
• The study will look at whether companies that manage drug benefits and insurance providers are getting paid fees based on a percentage of a drug's high price.
• Investigators will look for conflicts of interest, such as whether these companies choose expensive drugs over cheaper ones just to collect higher fees.
• The goal is to uncover hidden deals that might be making medicine more expensive for people using government programs like Medicare and Medicaid.
• The government watchdog must finish this study and give Congress a list of ways to fix these pricing problems within two years.

Impact Analysis

Govbase has not yet run an impact analysis on this legislation.